iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 364

Identifiers

  • Canonical SMILES: 
    CN1c2ncnn2[C@H](C2=C1c1cc(ccc1O[C@@H]2c1ccc(Br)cc1)C#N)c1ccc(Br)cc1
  • InChi: 
    InChI=1S/C26H17Br2N5O/c1-32-24-20-12-15(13-29)2-11-21(20)34-25(17-5-9-19(28)10-6-17)22(24)23(33-26(32)30-14-31-33)16-3-7-18(27)8-4-16/h2-12,14,23,25H,1H3/t23-,25+/m0/s1
  • InChiKey: 
    XTRRRBPSMDRWKB-UKILVPOCSA-N

External links


44549893

External search

Bibliography (1)

Publication Name
Allen JG, Bourbeau MP, Wohlhieter GE, Bartberger MD, Michelsen K, Hungate R, Gadwood RC, Gaston RD, Evans B, Mann LW, Matison ME, Schneider S, Huang X, Yu D, Andrews PS, Reichelt A, Long AM, Yakowec P, Yang EY, Lee TA, Oliner JD. . Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction. Journal of medicinal chemistry. 29

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
MDM2-Like / P53 5.51 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 572.98 g/mol
HBA 6
HBD 0
HBA + HBD 6
AlogP 6.36
TPSA 66.97
RB 2
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
19856920 29 MDM2
Q00987
Biochemical assay Time-Resolved FRET pIC50 (half maximal inhibitory concentration, -log10) 5.51
Ta Structure Name Drugbank ID
0.4233 BMS-394136 DB12067
0.3673 GDC-0927 DB14934
0.3413 (4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium DB02673
0.3393 LY-2881835 DB15046
0.3382 MK-1775 DB11740
0.3351 Desvancosaminyl vancomycin DB04529
0.3333 Naldemedine DB11691
0.3324 Vancomycin DB00512
0.3303 Parsaclisib DB14867
0.3282 Balhimycin DB04111
0.3276 Rocaglamide DB15495
0.3274 4-epi-vancosaminyl derivative of vancomycin DB04431
0.3267 Galicaftor DB14894
0.3267 Iclaprim DB06358
0.3267 (S)-iclaprim DB07938